AnalystsAndrew S. FeinAndrew S. Fein's Stock Forecasts
AnalystsAndrew S. Fein
Sectors:
Industries:
Analyst Ranking
Top 22%
#1111 out of 5067 analysts
Average Return
+26.05%
Win Rate
89%16 out of 18
Risk vs Reward
Poor
Good
Andrew S. Fein's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +72.71% | $8.61 | $14.87 | 2025-09-04 - 2025-09-19 | Buy |
Arvinas IncARVN | +55.13% | $6.24 | $9.68 | 2025-08-07 - 2025-10-16 | Buy |
Palvella Therapeutics IncPVLA | +54.63% | $47.30 | $73.14 | 2025-08-15 - 2025-10-16 | Buy |
Metavia IncMTVA | +51.38% | $0.69 | $1.04 | 2025-09-04 - 2025-10-16 | Buy |
Prothena Corp Public Ltd CoPRTA | +43.53% | $7.03 | $10.09 | 2025-08-05 - 2025-10-16 | Buy |
Andrew S. Fein Analyst Color
Get additional color on Andrew S. Fein's coverage of popular stocks
Andrew S. Fein's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Akero Therapeutics IncAKRO | 2 | Hold | $54.00 | +0.63% | Downgrades | 8 days ago |
Prothena Corp Public Ltd CoPRTA | 2 | Buy | $20.00 | +98.22% | Maintains | 11 days ago |
Liquidia CorpLQDA | 1 | Buy | $35.00 | +50.99% | Reiterates | 12 days ago |
Palvella Therapeutics IncPVLA | 2 | Buy | $95.00 | +29.89% | Maintains | 22 days ago |
89bio IncETNB | 2 | Hold | $14.50 | -1.83% | Downgrades | a month ago |
Kymera Therapeutics IncKYMR | 1 | Buy | $70.00 | +15.78% | Maintains | a month ago |
Terns Pharmaceuticals IncTERN | 1 | Hold | $7.44 | -13.59% | Assumes | a month ago |
Metavia IncMTVA | 1 | Buy | $12.00 | +1,053.85% | Assumes | a month ago |
Madrigal Pharmaceuticals IncMDGL | 1 | Buy | $500.00 | +13.09% | Assumes | a month ago |
Arcturus Therapeutics Holdings IncARCT | 1 | Buy | $60.00 | +176.12% | Assumes | a month ago |
Wave Life Sciences LtdWVE | 1 | Buy | $22.00 | +179.54% | Reiterates | a month ago |
Savara IncSVRA | 2 | Buy | $8.00 | +123.46% | Maintains | a month ago |
Insmed IncINSM | 1 | Buy | $240.00 | +47.07% | Maintains | 2 months ago |
Arvinas IncARVN | 1 | Buy | $18.00 | +85.95% | Maintains | 2 months ago |
Day One Biopharmaceuticals IncDAWN | 1 | Buy | $25.00 | +234.67% | Maintains | 2 months ago |
Vertex Pharmaceuticals IncVRTX | 1 | Buy | $478.00 | +16.98% | Maintains | 2 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.